Non-neutralizing SARS-CoV-2 N-terminal domain antibodies protect mice against severe disease using Fc-mediated effector functions

Supporters

Support the authors with ResearchCoin

Tip RSC

Preprint Server

Topics

Biology

Immunology

Virology

Antibody

Virus

Show all topics

DOI

10.1101/2023.07.25.550460

License

CC-BY

Other Formats

PDF